Mark Leong – Executive Chairman – Osteopore (ASX:OSX) is a Singapore-headquartered corporation poised to be a leading medical device company in the region. It is involved in designing, developing and marketing bioresorbable polymer implants for neurosurgical, orthopedic, and maxillofacial surgery use.
Copyright 2023 – Finance News Network
Source: Finance News Network
10 Oct 2023 - Jon Price - Managing Director - Richmond Vanadium Technology (ASX:RVT) is an Australian minerals development company which is advancing the Richmond – Julia Creek Vanadium Project in Queensland through a Bankable Feasibility Study.
Read More27 May 2024 - Peter Barrett discusses how Australia can lead in quantum computing and AI by leveraging local talent, resources, and capital to build transformative companies and retain innovation.
Read More10 Mar 2025 - CEO Marc Voigt on Clinical Trials, Regulatory Milestones, and Market Growth
Read More02 Jun 2023 - Falcon Metals Limited (ASX:FAL) Managing Director Tim Markwell discusses progress with the company's gold exploration, touching on key prospects and the results timeline.
Read More21 Jun 2023 - Sayona Mining Limited (ASX:SYA) Finance Manager Dougal Elder discusses key takeaways from the recent lithium carbonate study, improvement in operation total value, and steps to get to first production in 2026.
Read More16 Mar 2022 - LBT Innovations Limited (ASX:LBT) CEO and Managing Director Brent Barnes discuses the company's recent sales win and its distribution agreement with distributor Thermo Fisher Scientific.
Read More08 Sep 2021 - Knosys Limited (ASX:KNO) Managing Director John Thompson discusses FY21 results and the outlook for FY22.
Read More25 March 2024 - Altech Batteries Limited (ASX:ATC) Managing Director Iggy Tan provides an update on the company, discussing funding pathways and the results of the DFS.
Read More21 Jul 2021 - icetana (ASX:ICE) CEO and Managing Director Matt Macfarlane provides an update for the June quarter 2021.
Read More27 Jan 2021 - Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt analyses December's breast cancer data, and provides an update on efti's position and outlook.e sites.
Read More
